Barclays’s Acumen Pharmaceuticals ABOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $35K | Sell |
29,991
-42,274
| -58% | -$49.3K | ﹤0.01% | 3999 |
|
|
2025
Q1 | $80K | Sell |
72,265
-20,817
| -22% | -$23K | ﹤0.01% | 3753 |
|
|
2024
Q4 | $161K | Buy |
93,082
+31,085
| +50% | +$53.8K | ﹤0.01% | 3609 |
|
|
2024
Q3 | $154K | Buy |
61,997
+40,551
| +189% | +$101K | ﹤0.01% | 3602 |
|
|
2024
Q2 | $52K | Sell |
21,446
-25,864
| -55% | -$62.7K | ﹤0.01% | 3660 |
|
|
2024
Q1 | $191K | Sell |
47,310
-37
| -0.1% | -$149 | ﹤0.01% | 3356 |
|
|
2023
Q4 | $182K | Buy |
47,347
+24,922
| +111% | +$95.8K | ﹤0.01% | 3540 |
|
|
2023
Q3 | $93K | Sell |
22,425
-2,969
| -12% | -$12.3K | ﹤0.01% | 3352 |
|
|
2023
Q2 | $122K | Sell |
25,394
-558
| -2% | -$2.68K | ﹤0.01% | 3324 |
|
|
2023
Q1 | $105K | Sell |
25,952
-8,509
| -25% | -$34.4K | ﹤0.01% | 3495 |
|
|
2022
Q4 | $185K | Buy |
34,461
+300
| +0.9% | +$1.61K | ﹤0.01% | 3131 |
|
|
2022
Q3 | $342K | Buy |
34,161
+27,437
| +408% | +$275K | ﹤0.01% | 2785 |
|
|
2022
Q2 | $32K | Sell |
6,724
-5,093
| -43% | -$24.2K | ﹤0.01% | 3907 |
|
|
2022
Q1 | $46K | Buy |
+11,817
| New | +$46K | ﹤0.01% | 4031 |
|